Jenny W. Wang

591 total citations
19 papers, 460 citations indexed

About

Jenny W. Wang is a scholar working on Molecular Biology, Ophthalmology and Pharmacology. According to data from OpenAlex, Jenny W. Wang has authored 19 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Ophthalmology and 6 papers in Pharmacology. Recurrent topics in Jenny W. Wang's work include Glaucoma and retinal disorders (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Estrogen and related hormone effects (3 papers). Jenny W. Wang is often cited by papers focused on Glaucoma and retinal disorders (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Estrogen and related hormone effects (3 papers). Jenny W. Wang collaborates with scholars based in United States, United Kingdom and Ireland. Jenny W. Wang's co-authors include David F. Woodward, W. Daniel Stamer, Roshantha A.S. Chandraratna, Yi Zhao, Jia‐Hao Xiao, Jose L. Martos, Corine Ghosn, Clive L. Cornell, Simon N. Pettit and Hans Fliri and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and British Journal of Pharmacology.

In The Last Decade

Jenny W. Wang

19 papers receiving 442 citations

Peers

Countries citing papers authored by Jenny W. Wang

Since Specialization

Citations

This map shows the geographic impact of Jenny W. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny W. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny W. Wang more than expected).

Fields of papers citing papers by Jenny W. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny W. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny W. Wang. The network helps show where Jenny W. Wang may publish in the future.

Co-authorship network of co-authors of Jenny W. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny W. Wang. A scholar is included among the top collaborators of Jenny W. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny W. Wang. Jenny W. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Identifying Core Journals in Otolaryngology: A Bibliometric Analysis 2023 ·The Laryngoscope ·(unknown), (unknown), (unknown), Jenny W. Wang, Edward C. Kuan, Tjoson Tjoa, Yarah M. Haidar	1
2	Effect of the Antiglaucoma Agent JV-GL1 and Related Compounds in the Canine Eye 2020 ·Journal of Ocular Pharmacology and Therapeutics ·David F. Woodward, Robert A. Coleman, (unknown), Clayton S. Spada, Jenny W. Wang	2
3	The role of EP₂receptors in mediating the ultra-long-lasting intraocular pressure reduction by JV-GL1 2020 ·British Journal of Ophthalmology ·Jacques Bertrand, David F. Woodward, Joseph M. Sherwood, Jenny W. Wang, Darryl R. Overby	4
4	A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes 2020 ·ACS Pharmacology & Translational Science ·David F. Woodward, Jenny W. Wang, Clayton S. Spada, Robert W. Carling, Jose L. Martos, Simon N. Pettit, (unknown), L. David Waterbury, Matthew S. Lawrence, Wenzheng Hu, Neil J. Poloso	2
5	A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method 2019 ·Journal of Ocular Pharmacology and Therapeutics ·David F. Woodward, Jenny W. Wang, Robert A. Coleman, (unknown), Kenneth L. Clark, W. Daniel Stamer, (unknown), Shan Fan, Carol B. Toris	10
6	Antiglaucoma EP ₂ Agonists: A Long Road That Led Somewhere 2019 ·Journal of Ocular Pharmacology and Therapeutics ·David F. Woodward, Jenny W. Wang, W. Daniel Stamer, Elke Lütjen-Drecoll, Achim H.‐P. Krauss, Carol B. Toris	10
7	In Vivo Choroidal Neovascularization and Macrophage Studies Provide Further Evidence for a Broad Role of Prostacyclin in Angiogenesis 2018 ·Journal of Ocular Pharmacology and Therapeutics ·David F. Woodward, Jenny W. Wang, Ming Ni, (unknown), Neil J. Poloso	3
8	FAAH-Catalyzed C–C Bond Cleavage of a New Multitarget Analgesic Drug 2018 ·ACS Chemical Neuroscience ·Alessia Ligresti, Cristoforo Silvestri, Rosa Maria Vitale, Jose L. Martos, Fabiana Piscitelli, Jenny W. Wang, Marco Allarà, Robert W. Carling, Livio Luongo, Francesca Guida, Anna Illiano, Angela Amoresano, Sabatino Maione, Pietro Amodeo, David F. Woodward, Vincenzo Di Marzo, Gennaro Marino	2
9	A Prostacyclin Analog, Cicaprost, Exhibits Potent Anti-Inflammatory Activity in Human Primary Immune Cells and a Uveitis Model 2017 ·Journal of Ocular Pharmacology and Therapeutics ·Jenny W. Wang, (unknown), Neil J. Poloso	13
10	In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti‐inflammatory effects 2016 ·The FASEB Journal ·David F. Woodward, Jenny W. Wang, Ming Ni, (unknown), Jose L. Martos, Robert W. Carling, Neil J. Poloso	8
11	Multitargeting of selected prostanoid receptors provides agents with enhanced anti‐inflammatory activity in macrophages 2015 ·The FASEB Journal ·Jenny W. Wang, David F. Woodward, Jose L. Martos, Clive L. Cornell, Robert W. Carling, Philip J. Kingsley, Lawrence J. Marnett	12
12	Differential Effects of Prostaglandin E₂-Sensitive Receptors on Contractility of Human Ocular Cells That Regulate Conventional Outflow 2013 ·Investigative Ophthalmology & Visual Science ·Jenny W. Wang, David F. Woodward, W. Daniel Stamer	37
13	Prostamide F₂_α receptor antagonism combined with inhibition of FAAH may block the pro‐inflammatory mediators formed following selective FAAH inhibition 2013 ·British Journal of Pharmacology ·Alessia Ligresti, Jose L. Martos, Jenny W. Wang, Francesca Guida, Marco Allarà, (unknown), Livio Luongo, David F. Woodward, Vincenzo Di Marzo	17
14	The prostamide‐related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias 2012 ·The FASEB Journal ·(unknown), David F. Woodward, Nilofer Farjo, Bessam Farjo, (unknown), Jenny W. Wang, Steven M. Picksley, Valerie A. Randall	50
15	Structural determinants for calcium mobilization by prostaglandin E2 and prostaglandin F2α glyceryl esters in RAW 264.7 cells and H1819 cells 2010 ·Prostaglandins & Other Lipid Mediators ·(unknown), Chaitanya S. Nirodi, Brenda C. Crews, David F. Woodward, Jenny W. Wang, (unknown), Lawrence J. Marnett	21
16	Cellular Basis for Bimatoprost Effects on Human Conventional Outflow 2010 ·Investigative Ophthalmology & Visual Science ·W. Daniel Stamer, David Piwnica, Thierry Jolas, Robert W. Carling, Clive L. Cornell, Hans Fliri, Jose L. Martos, Simon N. Pettit, Jenny W. Wang, David F. Woodward	35
17	Bimatoprost, Prostamide Activity, and Conventional Drainage 2007 ·Investigative Ophthalmology & Visual Science ·(unknown), David F. Woodward, Clive L. Cornell, Hans Fliri, Jose L. Martos, Simon N. Pettit, Jenny W. Wang, (unknown), Larry A. Wheeler, Michael E. Garst, (unknown), (unknown), W. Daniel Stamer	68
18	Adenomatous Polyposis Coli (APC)-independent Regulation of β-Catenin Degradation via a Retinoid X Receptor-mediated Pathway 2003 ·Journal of Biological Chemistry ·Jia‐Hao Xiao, Corine Ghosn, (unknown), (unknown), Jenny W. Wang, (unknown), (unknown), Yi Zhao, Roshantha A.S. Chandraratna	130
19	Recruitment of Nuclear Receptor Corepressor and Coactivator to the Retinoic Acid Receptor by Retinoid Ligands 2000 ·Journal of Biological Chemistry ·Elliott Klein, Jenny W. Wang, (unknown), (unknown), Roshantha A.S. Chandraratna	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact